Differential roles for cholecystokinin A receptors in energy balance in rats and mice

Endocrinology

Volumn 145, Issue 8, 2004, Pages 3873-3880

  Bi, Sheng ^a   Scott, Karen A ^a   Kopin, Alan S ^b   Moran, Timothy H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; DEVAZEPIDE; MESSENGER RNA; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENERGY BALANCE; FEEDING BEHAVIOR; FOOD INTAKE; GENE EXPRESSION; HYPOTHALAMUS NUCLEUS; MALE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT STRAIN;

ANIMALS; ENERGY METABOLISM; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALE; MICE; NEUROPEPTIDE Y; RATS; RATS, LONG-EVANS; RECEPTOR, CHOLECYSTOKININ A; RNA, MESSENGER;

EID: 3843119853     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0284     Document Type: Article

References (49)

1. Gibbs J, Young RC, Smith GP 1973 Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84:488-495
2. Anika SM, Houpt TR, Houpt KA 1981 Cholecystokinin and satiety in pigs. Am J Physiol 240:R310-R318
3. Gibbs J, Falasco JD, McHugh PR 1976 Cholecystokinin-decreased food intake in rhesus monkeys. Am J Physiol 230:15-18
4. Kissileff HR, Pi-Sunyer FX, Thornton J, Smith GP 1981 C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr 34:154-160
5. West DB, Fey D, Woods SC 1984 Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol 246:R776-R787
6. Shillabeer G, Davison JS 1984 The Cholecystokinin antagonist, proglumide, increases food intake in the rat. Regul Pept 8:171-176
7. Moran TH, Ameglio PJ, Schwartz GJ, McHugh PR 1992 Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am J Physiol 262:R46-R50
8. Reidelberger RD, O'Rourke MF 1989 Potent cholecystokinin antagonist L 364718 stimulates food intake in rats. Am J Physiol 257:R1512-R1518
9. Silver AJ, Flood JF, Song AM, Morley JE 1989 Evidence for a physiological role for CCK in the regulation of food intake in mice. Am J Physiol 256:R646-R652
10. Moran TH, Ameglio PJ, Peyton HJ, Schwartz GJ, McHugh PR 1993 Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. Am J Physiol 265:R620-R624
11. Smith GP, Gibbs J 1994 Satiating effect of cholecystokinin. Ann NY Acad Sci 713:236-241
12. Della-Fera MA, Baile CA 1979 Cholecystokinin octapeptide: continuous picomole injections into the cerebral ventricles of sheep suppress feeding. Science 206:471-473
13. Schick RR, Yaksh TL, Go VL 1986 Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats-pharmacological characterization of this action. Regul Pept 14:277-291
14. Crawley JN 1985 Clarification of the behavioral functions of peripheral and central cholecystokinin: two separate peptide pools. Peptides 6(Suppl 2):129-136
15. Blevins JE, Stanley BG, Reidelberger RD 2000 Brain regions where cholecystokinin suppresses feeding in rats. Brain Res 860:1-10
16. Blevins JE, Hamel FG, Fairbairn E, Stanley BG, Reidelberger RD 2000 Effects of paraventricular nucleus injection of CCK-8 on plasma CCK-8 levels in rats. Brain Res 860:11-20
17. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T 1992 Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima fatty (OLETF) strain. Diabetes 41:1422-1428
18. Takiguchi S, Takata Y, Funakoshi A, Miyasaka K, Kataoka K, Fujimura Y, Goto T, Kono A 1997 Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene 197:169-175
19. Bi S, Moran TH 2002 Actions of CCK in the controls of food intake and body weight: lessons from the CCK-A receptor deficient OLETF rat. Neuropeptides 36:1-11
20. Moran TH, Katz LF, Plata-Salaman CR, Schwartz GJ 1998 Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am J Physiol 274:R618-R625
21. Bi S, Ladenheim EE, Schwartz GJ, Moran TH 2001 A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. Am J Physiol 281:R254-R260
22. Kopin AS, Mathes WF, McBride EW, Nguyen M, Al-Haider W, Schmitz F, Bonner-Weir S, Kanarek R, Beinborn M 1999 The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest 103:383-391
23. Castonguay TW, Kaiser LL, Stern JS 1986 Meal pattern analysis: artifacts, assumptions and implications. Brain Res Bull 17:439-443
24. Wank SA, Harkins R, Jensen RT, Shapira H, de Weerth A, Slattery T 1992 Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 89:3125-3129
25. Bi S, Robinson BM, Moran TH 2003 Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression. Am J Physiol 285:R1030-R1036
26. Higuchi H, Yang HY, Sabol SL 1988 Rat neuropeptide Y precursor gene expression. mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP, and phorbol ester. J Biol Chem 263:6288-6295
27. Franklin KBJ, Paxinos G 1997 The mouse brain in stereotaxic coordinates. San Diego: Academic Press
28. Moran TH, Robinson PH, Goldrich MS, McHugh PR 1986 Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res 362:175-179
29. Broberger C 1999 Hypothalamic cocaine- and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y. Brain Res 848:101-113
30. Grouzmann E, Comoy E, Walker P, Burnier M, Bohuon C, Waeber B, Brunner H 1992 Production and characterization of four anti-neuropeptide Y monoclonal antibodies. Hybridoma 11:409-424
31. Paxinos G, Watson C 1986 The rat brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press
32. Sergeyev V, Broberger C, Gorbatyuk O, Hokfelt T 2000 Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus. Neuroreport 11:117-121
33. Seoane LM, Lopez M, Tovar S, Casanueva FF, Senaris R, Dieguez C 2003 Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144: 544-551
34. Woodruff GN, Hill DR, Boden P, Pinnock R, Singh L, Hughes J 1991 Functional role of brain CCK receptors. Neuropeptides 19(Suppl):45-56
35. Honda T, Wada E, Battey JF, Wank SA 1993 Differential gene expression of CCK-A and CCK-B receptors in the rat brain. Mol Cell Neurosci 4:143-154
36. Smith MS 1993 Lactation alters neuropeptide-Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat. Endocrinology 133:1258-1265
37. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
38. Kesterson RA, Huszar D, Lynch CA, Simerly RB, Cone RD 1997 Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol Endocrinol 11:630-637
39. Guan XM, Yu H, Trumbauel M, Frazier E, Van der Ploeg LH, Chen H 1998 Induction of neuropeptide Y expression in dorsomedial hypothalamus of diet-induced obese mice. Neuroreport 9:3415-3419
40. Thompson RH, Ganteras NS, Swanson LW 1996 Organization of projections from the dorsomedial nucleus of the hypothalamus: a PHA-L study in the rat. J Comp Neurol 376:143-173
41. Bellinger LL, Bernardis LL 2002 The dorsomedial hypothalamic nucleus and its role in ingestive behavior and body weight regulation: lessons learned from lesioning studies. Physiol Behav 76:431-442
42. Bellinger LL, Castonguay TW, Bernardis LL 1994 Hormone and somatic changes in rats pair-fed to growth retarded dorsomedial hypothalamic nuclei-lesioned rats. Brain Res Bull 34:117-124
43. Hill DR, Woodruff GN 1990 Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260. Brain Res 526:276-283
44. Figlewicz DP, Nadzan AM, Sipols AJ, Green PK, Liddle RA, Porte Jr D, Woods SC 1992 Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors. Am J Physiol 263:R863-R867
45. Inoue H, Iannotti CA, Welling CM, Veile R, Donis-Keller H, Permutt MA 1997 Human cholecystokinin type A receptor gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM). Genomics 42:331-335
46. Miller LJ, Holicky EL, Ulrich CD, Wieben ED 1995 Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology 109:1375-1380
47. Funakoshi A, Miyasaka K, Matsumoto H, Yamamori S, Takiguchi S, Kataoka K, Takata Y, Matsusue K, Kono A, Shimokata H 2000 Gene structure of human cholecystokinin (CCK) type-A receptor: body fat content is related to CCK type-A receptor gene promoter polymorphism. FEBS Lett 466:264-266
48. Marchal-Victorion S, Vionnet N, Escrieut C, Dematos F, Dina C, Dufresne M, Vaysse N, Pradayrol L, Froguel P, Fourmy D 2002 Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients. Pharmacogenetics 12:23-30
49. Watanabe TK, Okuno S, Oga K, Mizoguchi-Miyakita A, Tsuji A, Yamasaki Y, Hishigaki H, Kanemoto N, Takagi T, Takahashi E, Irie Y, Nakamura Y, Tanigami A 1999 Genetic dissection of "OLETF," a rat model for non-insulin-dependent diabetes mellitus: quantitative trait locus analysis of (OLETF X BN) x OLETF. Genomics 58:233-239